Equity Overview
Price & Market Data
Price: $6.78
Daily Change: -$0.19 / 2.80%
Range: $6.76 - $7.13
Market Cap: $157,945,536
Volume: 69,833
Performance Metrics
1 Week: -8.25%
1 Month: 13.57%
3 Months: 29.14%
6 Months: 24.63%
1 Year: 19.37%
YTD: 73.40%
Company Details
Employees: 41
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Emrosi for the treatment of inflammatory lesions of rosacea, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.